Therapeutic drugs and treatment of SARS-CoV-2
10.12092/j.issn.1009-2501.2020.06.015
- VernacularTitle: 抗新型冠状病毒药物与治疗浅谈
- Author:
Yuqi HAO
1
Author Information
1. Tianjia Genomes Tech CO., LTD.
- Publication Type:Journal Article
- Keywords:
Clinical trials;
Research and development ideas;
Research of new drug;
SARS-CoV-2
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2020;25(6):716-720
- CountryChina
- Language:Chinese
-
Abstract:
Novel coronavirus pneumonia caused by the SARS-CoV-2 appeared in Wuhan, China in December 2019. The virus spread rapidly across the country and resulted in the infection of more than 80 000 people by March 8, 2020. This paper introduces the data of tested drugs in vitro, in animal and in clinical trials marketed and in research, in hoping of providing reference for the prevention and control of SARS-CoV-2.
